Agriculture
From ANIMAL PEOPLE, June 1993:
The Food and Drug Admini-
stration held hearings May 6-7 on whether
to approve the sale of milk produced with
the aid of the genetically engineered hor-
mone bovine somatotropin (BST), and if
sale is approved, whether the milk should
be specially labeled. Four chemical
firms––Upjohn, Monsanto, American
Cyanamid, and Eli Lilly––have reportedly
spent $500 million to develop and introduce
BST, which boosts milk production per cow
by up to 20%. BST is opposed by con-
sumer groups concerned about the possible
effects of the drug on human health, which
may include altering the growth rate of
bone and liver cells; animal protection
groups worried that BST may increase the
stress on cows; and dairy farmers anxious
that many of them could be put out of busi-
ness, since BST enables fewer cows to pro-
duce more milk, which is already in over-
supply. The same debate is underway in
Canada, where a multi-department review
of the possible effects of BST is to be com-
pleted later this year.